Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 31589 | 121 | 42.4 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2307 | 4094 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | WIG 1 | Author keyword | 26 | 100% | 9% | 11 |
| 2 | OSTEOACTIVIN | Author keyword | 26 | 80% | 13% | 16 |
| 3 | GPNMB | Author keyword | 13 | 67% | 10% | 12 |
| 4 | GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B | Author keyword | 6 | 100% | 3% | 4 |
| 5 | DC HIL | Author keyword | 3 | 100% | 2% | 3 |
| 6 | GLYCOPROTEIN NMB | Author keyword | 3 | 100% | 2% | 3 |
| 7 | EC109 | Author keyword | 2 | 67% | 2% | 2 |
| 8 | CDX 011 | Author keyword | 1 | 100% | 2% | 2 |
| 9 | CR011 VCMMAE | Author keyword | 1 | 100% | 2% | 2 |
| 10 | GLYCOPROTEIN NONMETASTATIC MELANOMA B | Author keyword | 1 | 100% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | WIG 1 | 26 | 100% | 9% | 11 | Search WIG+1 | Search WIG+1 |
| 2 | OSTEOACTIVIN | 26 | 80% | 13% | 16 | Search OSTEOACTIVIN | Search OSTEOACTIVIN |
| 3 | GPNMB | 13 | 67% | 10% | 12 | Search GPNMB | Search GPNMB |
| 4 | GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B | 6 | 100% | 3% | 4 | Search GLYCOPROTEIN+NON+METASTATIC+MELANOMA+PROTEIN+B | Search GLYCOPROTEIN+NON+METASTATIC+MELANOMA+PROTEIN+B |
| 5 | DC HIL | 3 | 100% | 2% | 3 | Search DC+HIL | Search DC+HIL |
| 6 | GLYCOPROTEIN NMB | 3 | 100% | 2% | 3 | Search GLYCOPROTEIN+NMB | Search GLYCOPROTEIN+NMB |
| 7 | EC109 | 2 | 67% | 2% | 2 | Search EC109 | Search EC109 |
| 8 | CDX 011 | 1 | 100% | 2% | 2 | Search CDX+011 | Search CDX+011 |
| 9 | CR011 VCMMAE | 1 | 100% | 2% | 2 | Search CR011+VCMMAE | Search CR011+VCMMAE |
| 10 | GLYCOPROTEIN NONMETASTATIC MELANOMA B | 1 | 100% | 2% | 2 | Search GLYCOPROTEIN+NONMETASTATIC+MELANOMA+B | Search GLYCOPROTEIN+NONMETASTATIC+MELANOMA+B |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DC HIL | 44 | 85% | 19% | 23 |
| 2 | OSTEOACTIVIN | 21 | 69% | 15% | 18 |
| 3 | GPNMB | 14 | 100% | 6% | 7 |
| 4 | MELANOMA PROTEIN B | 10 | 73% | 7% | 8 |
| 5 | GLEMBATUMUMAB VEDOTIN | 3 | 100% | 2% | 3 |
| 6 | PAG608 | 3 | 100% | 2% | 3 |
| 7 | P53 ACTIVATED GENE | 2 | 67% | 2% | 2 |
| 8 | AURISTATIN E | 2 | 50% | 2% | 3 |
| 9 | CR011 VCMMAE | 1 | 100% | 2% | 2 |
| 10 | GLYCOPROTEIN NONMETASTATIC B | 1 | 100% | 2% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Gpnmb/osteoactivin, an attractive target in cancer immunotherapy | 2012 | 8 | 39 | 85% |
| Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer | 2013 | 11 | 98 | 49% |
| Management of Metastatic Breast Cancer with Second-Generation Antibody-Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE) | 2014 | 1 | 52 | 42% |
| The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? | 2011 | 10 | 65 | 18% |
| Effect of Altered WIG-1 Expression on DDP Sensitivity in a DDP-Resistant Esophageal Squamous Cancer Cell Line | 2012 | 1 | 40 | 23% |
| Regulation of tumor suppressor p53 at the RNA level | 2010 | 27 | 95 | 7% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL ENZYME CHEM | 1 | 50% | 0.8% | 1 |
| 2 | MRC MOL ONCOL GRP | 1 | 50% | 0.8% | 1 |
| 3 | TRI SERV ORTHODONT IDENCY PROGRAM | 1 | 50% | 0.8% | 1 |
| 4 | ONCOL HEMATOL IMMUNOL RHEUMATOL PULMOL | 1 | 25% | 1.7% | 2 |
| 5 | BREAST MOL ONCOL | 0 | 25% | 0.8% | 1 |
| 6 | DUNN DENT CLIN | 0 | 25% | 0.8% | 1 |
| 7 | HLTH PROFESSIONS | 0 | 25% | 0.8% | 1 |
| 8 | CANC KAROLINSKA R8 04 | 0 | 20% | 0.8% | 1 |
| 9 | BIOL TREATMENT METASTASES | 0 | 17% | 0.8% | 1 |
| 10 | ORTHOPAED SURG SPORT MED | 0 | 14% | 0.8% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000196041 | ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1 |
| 2 | 0.0000069133 | ODZ//TEN M//TENEURIN |
| 3 | 0.0000061607 | MELANOGENESIS//MITF//TYROSINASE |
| 4 | 0.0000058451 | PERIOSTIN//PERIOSTIN LIKE FACTOR//POSTN |
| 5 | 0.0000058145 | ARTIFICIAL TRANSCRIPTION FACTOR//ARTIFICIAL TRANSCRIPTION FACTORS//RECOGNITION CODE |
| 6 | 0.0000057001 | SPARC//OSTEONECTIN//BM 40 |
| 7 | 0.0000052064 | PROLYLCARBOXYPEPTIDASE//PRCP//ANGIOTENSINASE C |
| 8 | 0.0000050084 | SERGLYCIN//SERGLYCIN PROTEOGLYCAN//KIDNEY SECT |
| 9 | 0.0000048681 | KRAB DOMAIN//KRAB//SCAN DOMAIN |
| 10 | 0.0000046346 | CHROMOSOME 3Q26//PAN RAS//HUMAN TELOMERASE GENE |